We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen’s Vectibix OK’d in EU to Treat Metastatic Colorectal Cancer
Amgen’s Vectibix OK’d in EU to Treat Metastatic Colorectal Cancer
The European Medicines Agency has approved a new use of Amgen’s Vectibix as first-line treatment in combination with Folfiri chemotherapy for metastatic colorectal cancer, the drugmaker said Monday.